PainReform sets IPO terms with plans to offer 2.55 million units

PainReform Ltd., an Israeli start up that is aiming to develop non-opioid post-surgery pain treatments, set terms for its initial public offering on Monday, with plans to offer 2.55 million units priced at…

$8 to $10 each.

Each unit will consist of one ordinary share and a warrant to purchase a share, the company said in a regulatory filing. The company has applied to list on Nasdaq under the ticker “PRFX.”

Maxim Group and Joseph Gunnar & Co. are underwriting the deal.

Proceeds will be used to fund clinical trials, and for general corporate purposes.

“Our proprietary extended release drug-delivery system is designed to provide an…

Continue reading at



You May Also Like

About the Author: Admin